GlassScriptPhysician profile
Robert C Gambrell
NPI 1952353542
$208.76
in general payments reported to CMS, 2019-2025
10 companies · $89.74 in 2025
The $89.74 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.80 · 2022: $46.93 · 2024: $57.29 · 2025: $89.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $38.11 | 2025 | Korlym |
| Horizon Therapeutics Plc | $31.19 | 2022 | |
| Novo Nordisk INC | $24.86 | 2024 | Wegovy |
| Merck Sharp & Dohme LLC | $19.96 | 2025 | Verquvo |
| Lilly USA, LLC | $17.85 | 2024 | Mounjaro, Zepbound |
| Sumitomo Pharma America, INC. | $17.78 | 2025 | Gemtesa |
| Abbott Laboratories | $15.74 | 2022 | |
| Boston Scientific Corporation | $14.80 | 2019 | |
| Radius Health, INC. | $14.58 | 2024 | |
| Amgen INC. | $13.89 | 2025 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gambrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.